biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by james700on Feb 27, 2015 10:57am

95 Views

Post# 23471863

RE:ATTENTION: NON-BIOASIS SHAREHOLDERS

With a volume of 8,000 shares traded today, I guess there is not a HUGE demand. In a low volume environment like BTI's, if you wanted to buy 100,000 shares you would buy at a premium YES and then if you decided to sell those same 100,000 you would sell at a discount. Conclusion this stock is only good for small investors until concrete news and volume are present. Trade a million shares and we'll talk... Later

Bullboard Posts

Changing Europe’s dependency on HREE from China